Pharmacology
#B-352 | (R)(+)-Bay K8644 | Blocker | CaV1.2 #L-110 | L-651,582 | Blocker | CaV1.2 #B-350 | (±)-Bay K8644 | Activator | CaV1.2 #B-351 | (S)(-)-Bay K8644 | Activator | CaV1.2 #F-160 | FPL 64176 | Activator | CaV1.2 #S-105 | SR 33805 oxalate | Blocker | CaV1.2 #C-135 | Cilnidipine | Blocker | CaV1.2 #L-125 | Lomerizine dihydrochloride | Blocker | CaV1.2 #B-120 | Benidipine hydrochloride | Blocker | CaV1.2 #L-125 | Lomerizine dihydrochloride | Blocker | CaV1.2 #I-100 | Isradipine | Blocker | CaV1.3 #G-140 | GV-58 | Activator | CaV2.1 #F-120 | FTX-3.3 | Blocker | CaV2.1 #F-130 | sFTX-3.3 | Blocker | CaV2.1 #E-155 | Eliprodil | Blocker | CaV2.1 #P-105 | PD 173212 | Blocker | CaV2.2 #C-135 | Cilnidipine | Blocker | CaV2.2 #E-155 | Eliprodil | Blocker | CaV2.2 #T-140 | TTA-A2 | Blocker | CaV3.1 #B-120 | Benidipine hydrochloride | Blocker | CaV3.1 #T-155 | TTA-P2 | Blocker | CaV3.2 #N-206 | NNC 55-0396 dihydrochloride hydrate | Blocker | CaV3.2 #T-210 | TTA-P2 (S-enantiomer) | Blocker | CaV3.2 #M-165 | ML 218 | Blocker | CaV3.2 #M-166 | ML 218 hydrochloride | Blocker | CaV3.2 #L-140 | L-Ascorbic acid | Blocker | CaV3.2 #M-150 | Mibefradil dihydrochloride hydrate | Blocker | CaV3.2
Dynamic Tips Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.